戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 l acute respiratory distress syndrome (ARDS) diagnostic agent.
2  gateway for the delivery of therapeutic and diagnostic agents.
3 used approach to prepare molecular tools and diagnostic agents.
4 produced and examined as potential companion diagnostic agents.
5    Nanoparticles are frequently suggested as diagnostic agents.
6 ghly specific toxin-specific therapeutic and diagnostic agents.
7 prove delivery efficiency of therapeutic and diagnostic agents.
8 inding ligands for targeted therapeutics and diagnostic agents.
9 seful for the design of both therapeutic and diagnostic agents.
10 g, and controlled release of therapeutic and diagnostic agents.
11 ide a novel delivery system for contrast and diagnostic agents.
12 ied for developing targeted chemotherapy and diagnostic agents.
13                   Delivery of therapeutic or diagnostic agents across an intact blood-brain barrier (
14 that functions as a combined therapeutic and diagnostic agent against cancer.
15 ave considerable potential as therapeutic or diagnostic agents against many neurological diseases.
16  could be a very early, highly specific ARDS diagnostic agent and may be useful to detect a wide rang
17 sense-based or antigene-based genetic tools, diagnostic agents and drugs, especially for those situat
18 unning occurs due to 74 MBq (131)I used as a diagnostic agent before (131)I ablation, it has no signi
19 ing avenue for the design of therapeutic and diagnostic agents, but the limited understanding of thei
20 in nanomedicine as drug delivery vectors and diagnostic agents, but the skin toxicity and irritation
21 been demonstrated to enable incorporation of diagnostic agents, drugs, and nucleic acids such as siRN
22 t multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be deliv
23 M. leprae ESAT-6 shows promise as a specific diagnostic agent for leprosy.
24 ters for Disease Control and Prevention as a diagnostic agent for the causative agent of plague.
25 ad compounds for the development of improved diagnostic agents for AD.
26 e development of new therapeutic VNAs and/or diagnostic agents for anthrax.
27 d lead to the development of new imaging and diagnostic agents for cancer.
28 molecular probes can be developed as in vivo diagnostic agents for melanoma and its metastases.
29 lyte affinity capture by surface-immobilized diagnostic agents is a routinely used assay format for p
30 argeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nan
31 biologics and biosimilars as therapeutic and diagnostic agents is giving rise to new demands for anal
32 or the design of metal-based therapeutic and diagnostic agents, macrocycles are rigid enough to provi
33 their capacity to carry other therapeutic or diagnostic agents may potentially offer capabilities for
34 herefore, we have begun to evaluate novel AD diagnostic agents that can be radiolabeled with (64)Cu,
35  nanoparticles containing therapeutic and/or diagnostic agents that can bind to the bispecific protei
36 e in mice using doses of the nanoparticulate diagnostic agents that fall under regulatory guidelines
37 besin peptide analogues results in promising diagnostic agents that retain high receptor binding acti
38 ide a powerful tool for evaluating drugs and diagnostic agents that target the various pathways influ
39  (89)Zr-labeled SC16 antibody as a companion diagnostic agent to facilitate selection of patients for
40 eptides for the transport of therapeutic and diagnostic agents to acidic tissue sites associated with
41 ool for targeted delivery of therapeutic and diagnostic agents to breast cancers and perhaps other ty
42 nge of affinities for many amyloid-targeting diagnostic agents under current development.
43 al packaging and delivery of therapeutic and diagnostic agents, were constructed using a quick and ef

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。